May 15, 2020
Mirati Therapeutics To Present Preclinical Data From Investigational Pipeline Of Novel Therapeutics At 2020 American Association For Cancer Research Virtual Annual Meeting II
Apr 30, 2020
Data From EMD Serono at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
Sep 23, 2019
New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care
Sep 17, 2019
Amgen Showcases New Data From Oncology Pipeline And Portfolio At ESMO 2019
Apr 24, 2019
OncoSec Appoints Industry Veteran Margaret R. Dalesandro, Ph.D., to it's Board of Directors
Nov 01, 2018
Radiation/cisplatin combination established as standard of care for HPV-related head and neck cancer
Sep 24, 2018
Okayama University Research: Insights Into Mechanisms Governing the Resistance to the Anti-Cancer Medication Cetuximab
Aug 23, 2018
Global Colorectal Cancer (CRC) Drugs/ Therapeutic Market 2016-2022: Bristol-Myer Squibb and Merck are Anticipated to be Market Leaders by 2022
Aug 01, 2018
The global colorectal cancer (CRC) drugs market size is expected to reach USD 10.8 billion by 2022
Jun 25, 2018
Highlights of the ESMO 20th World Congress on Gastrointestinal Cancer
Jun 01, 2018
GoPath Laboratories Announces Launch of miR-31now(TM) Test for Patients with Metastatic Colorectal Cancer
May 16, 2018
Merck KGaA, Darmstadt, Germany Data at ASCO 2018 to Showcase Progress and Further Optionality of Oncology Pipeline
May 02, 2018
Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group
Feb 15, 2018
Global Colorectal Cancer Forecast and Market Analysis 2017-2036: Avastin will Remain the Leading Targeted Therapy
Feb 15, 2018
Global Head and Neck Cancer Disease Analysis 2017-2026: Forecasts, Treatment, Marketed Drugs & Pipeline
Aug 30, 2017
Merck KGaA, Darmstadt, Germany: Driving Innovation in Cancer Care at ESMO 2017 With New Data in Hard-to-Treat Cancers